BTCY vs. PETV, MBOT, PSTV, SSKN, NXGL, NURO, OSA, VAPO, GCTK, and INBS
Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include PetVivo (PETV), Microbot Medical (MBOT), Plus Therapeutics (PSTV), STRATA Skin Sciences (SSKN), NEXGEL (NXGL), NeuroMetrix (NURO), ProSomnus (OSA), Vapotherm (VAPO), GlucoTrack (GCTK), and Intelligent Bio Solutions (INBS). These companies are all part of the "surgical & medical instruments" industry.
Biotricity (NASDAQ:BTCY) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
Biotricity has a net margin of -125.43% compared to PetVivo's net margin of -1,016.64%. Biotricity's return on equity of 0.00% beat PetVivo's return on equity.
Biotricity has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.
3.9% of Biotricity shares are owned by institutional investors. Comparatively, 24.6% of PetVivo shares are owned by institutional investors. 20.5% of Biotricity shares are owned by company insiders. Comparatively, 20.1% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
PetVivo has lower revenue, but higher earnings than Biotricity. PetVivo is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.
Biotricity and PetVivo both received 0 outperform votes by MarketBeat users.
In the previous week, Biotricity had 3 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Biotricity and 0 mentions for PetVivo. Biotricity's average media sentiment score of 0.68 beat PetVivo's score of 0.00 indicating that Biotricity is being referred to more favorably in the media.
Summary
Biotricity beats PetVivo on 8 of the 13 factors compared between the two stocks.
Get Biotricity News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Biotricity Competitors List
Related Companies and Tools
